ANGLE (LON:AGL) Given Buy Rating at Berenberg Bank

ANGLE (LON:AGLGet Rating)‘s stock had its “buy” rating reaffirmed by Berenberg Bank in a research note issued on Monday, Digital Look reports. They presently have a GBX 195 ($2.45) target price on the stock. Berenberg Bank’s price objective would indicate a potential upside of 98.98% from the company’s current price.

LON AGL opened at GBX 98 ($1.23) on Monday. The firm has a market cap of ¬£230.45 million and a P/E ratio of -14.63. ANGLE has a 52-week low of GBX 71.70 ($0.90) and a 52-week high of GBX 143.90 ($1.81). The business’s 50-day moving average price is GBX 100.95 and its 200 day moving average price is GBX 109.46. The company has a quick ratio of 7.66, a current ratio of 8.01 and a debt-to-equity ratio of 5.80.

ANGLE Company Profile (Get Rating)

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products worldwide. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in cancer patient blood; and HyCEAD multiplex analysis system used as the downstream analysis tool in the ovarian cancer clinical application.

Read More

Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.